记者 吴卫群 到了品牌成熟期，《行动计划》又提出支持具有较强领先优势的国内外知名品牌集聚发展，升级首 发经济支持政策，支持新产品、新业态、新模式、新潮流在上海首创、首发；支持知名品牌企业设立全 球品牌管理中心和品牌总部，加快向产业链供应链上下游延伸，实现规模化、集团化发展。 "与纽约、伦敦、巴黎、东京等国际消费中心城市相比，上海有着独特的发展优势。"中商数据联合 创始人周长青认为，上海培育品牌的底气就在于1小时都市圈内覆盖世界级制造产业链与外贸航运枢 纽，为品牌发展提供了坚实的产业基础，而乐于尝新求变的消费群体，又为品牌创新提供了广阔的市场 土壤。《行动计划》将加速上海消费价值链闭环的形成，为国际消费中心城市建设注入持久动力。 精准施策"人和钱"布局 品牌竞争的核心，始终是要素支撑的竞争。《行动计划》在人才与金融领域的布局，恰是直击品牌 发展痛点的精准施策。 对新锐品牌急需的高级管理人才，"落户直通车"打破人才流动壁垒；对老字号品牌，加强掌门人、 传承人与工匠队伍建设。更值得关注的是，上海将着力引进国际一流商业品牌管理人才、建立全市专业 人才库。 品牌强，则企业强；品牌兴，则城市兴。昨天，《加强上海商业品牌建 ...

凤凰网财经讯 9月23-24日，由凤凰卫视、凤凰网主办的"凤凰湾区财经论坛2025"在广州举行，本届论坛以"新格局·新路径"为主题，汇聚全球政商学界精 英，共同洞察变局脉络、探寻发展新机。 蔡冠深 全国政协常委、香港中华总商会会长、香港新华集团主席 全国政协常委、香港中华总商会会长、香港新华集团主席蔡冠深在演讲中谈到如何建设打造国际品牌中心时表示，将从以下三个方面入手： 最后，蔡冠深表示，品牌强国，企业出海，中国还有相当长的路要走。希望在大家的共同努力下，将一国两制下的香港国际品牌中心，成功打造成为中国企 业走向海外的强大助推器，成为中国品牌走向世界、世界品牌走进中国的双向的黄金跳板；成为中国标准和品牌规范服务全球、引领潮流的广阔舞台。 一，向联合国教科文组织申请以香港为"世界品牌日"的永久主办地，并为之设立一系列节庆、研讨和展销活动。 二，由国际品牌科学院连手香港各大商会，特区政府和中国商务部、内地不同的工商协会、行业协会，中外企业等，共同推动RCEP、一带一路沿线国家在 香港举办一年一度的"世界品牌及知识产权交易会"。为全球品牌的传播与展示，合作与交易，规划和扩展，搭建高质量的世界级平台。 三，构建世界级 ...

Group 1 - The "2025 Home Industry Strong Brand Forum" was successfully held in Guangzhou, focusing on the potential of the domestic consumption market and the transition from "demand-driven" to "quality-driven" home consumption [2][4] - The forum emphasized the importance of brand building in the home industry, highlighting the shift from "Made in China" to "Chinese Brands" and the broad development prospects for Chinese home brands [4][6] - The event gathered representatives from various sectors of the home industry, including doors, custom furniture, and hardware, to discuss high-quality development paths [2][6] Group 2 - Keynote speeches addressed industry challenges such as overcapacity and the need for collaboration, with a focus on meeting consumer needs through product innovation [8][10] - Companies like Ling Shang and OPK shared their global strategies and product trends, emphasizing the importance of creating flexible and intelligent home solutions [12][14] - The forum also included discussions on production technology and innovation in engineered wood products, showcasing advancements in eco-friendly and high-quality materials [16][17][19]

Group 1 - BYD has become a "CCTV Science and Technology Strong Country Strategic Partner," joining the "Brand Strong Country Project" to promote brand development and high-quality economic growth through technological innovation, showcasing its strength as a global leader in the electric vehicle sector [1][7] - In 2024, BYD achieved global sales of 4.2721 million units, maintaining its position as the top-selling automotive brand in China and the leading player in the global new energy vehicle market, reflecting its commitment to the principle of "technology as king, innovation as fundamental" [3] - BYD's R&D investment reached 54.2 billion yuan in 2024, a 36% increase year-on-year, with cumulative R&D spending exceeding 180 billion yuan, leveraging disruptive technologies such as blade batteries and DM-i to create a vast "technology pool" [3] Group 2 - BYD's multi-brand strategy includes the Dynasty, Ocean, Fangchengbao, Tengshi, and Yangwang brands, catering to diverse consumer needs from family to luxury vehicles, thereby enhancing the value of Chinese automotive brands [5] - The partnership with CCTV serves as an accelerator for BYD's development and a global expression of China's technological innovation narrative, with its electric vehicles now present in over 110 countries and regions [7] - Through this collaboration, BYD aims to refresh global perceptions of Chinese brands by leveraging innovative technologies and products, contributing Chinese wisdom to the world [9]

Core Insights - The Chinese bicycle industry is transitioning from a "sales-driven" model to one focused on "structural optimization, quality upgrades, and smart experiences" [1][2] - The market for mid-to-high-end bicycles saw significant growth in early 2024 but is now experiencing a rationalization of demand, leading to price reductions and profit compression for some brands [1][3] Market Trends - The demand for mid-to-high-end sports bicycles surged over 20% in early 2024 but began to cool down by August, indicating a shift towards more rational consumer behavior [1][3] - Consumers are increasingly prioritizing brand value, user experience, and community culture, leading to the development of integrated consumption scenarios such as "cycling + fitness" and "cycling + socializing" [2] Electric Bicycle Growth - The electric bicycle segment is projected to be a major growth area in 2025, with a rebound expected after a 15.6% decline in production due to industry standard adjustments [3] - In Q1 2025, production from large-scale enterprises is expected to grow by 38.5% year-on-year, driven by new policies and urbanization trends [3] - The market for electric bicycles in lower-tier cities is expanding, focusing on practical uses such as commuting and delivery [3] International Market Dynamics - In 2024, China exported 47.814 million bicycles, a 20.7% increase, with electric bicycle exports reaching 4.672 million units, up 12% [6][10] - The export value of bicycles reached $2.664 billion, reflecting a 3.7% increase, with significant growth in exports to emerging markets like Indonesia and Canada [6][7] - The cancellation of anti-dumping duties on non-folding electric bicycles by the UK opens new opportunities for Chinese exports to Europe [7] Industry Transformation - The Chinese bicycle industry is undergoing a transformation towards globalization, high-end products, and smart technology, with a focus on improving export product structures [8] - The shift from low-cost commuting bicycles to higher-value electric and smart products is becoming more pronounced [8] - The industry is expected to achieve over 10% growth in electric bicycle exports by 2025, supported by policy initiatives and product innovations [8] Financial Performance - In 2024, the total production of bicycles in China was approximately 99.537 million units, with a slight year-on-year increase of 0.4% [9][10] - The industry's revenue reached approximately 307.5 billion yuan, a 2.4% increase, while profits decreased by 6.8% to 12.46 billion yuan, indicating a stable profit margin [10]

Group 1 - The core initiative of Yiling Pharmaceutical is to promote the "Quality China" construction and high-quality development by enhancing brand recognition and storytelling for Chinese brands, particularly in the context of the upcoming "China Brand Day" in 2025 [3] - Yiling Pharmaceutical has launched the "5·10 Yiling Brand Month" series of activities in collaboration with nearly a hundred well-known chain pharmacies across the country, focusing on the theme "Technology Empowers Health, Brand Leads the Future" [3][4] - The activities will include public welfare science popularization, chronic disease management, and digital services to improve public health literacy and contribute positively to the construction of a healthy China [3][4] Group 2 - During the "5·10 Yiling Brand Month," Yiling Pharmaceutical will integrate quality medical resources through a multi-dimensional approach, including online science popularization and offline services, to provide comprehensive health service experiences for consumers [4] - The initiative will involve expert online live broadcasts and offline health screenings and consultations for chronic diseases, promoting the concept of "early screening, early diagnosis, early intervention" [4] - Yiling Pharmaceutical will collaborate with well-known chain pharmacies to conduct public health science roadshows across the country, aiming to enhance public access to health knowledge and services [4] Group 3 - Yiling Pharmaceutical has established a unique technological core competitiveness through the systematic construction of the theory of collateral diseases, which has led to significant technological innovations and the completion of multiple major projects [5][6] - The company has received six national science and technology awards and has developed patented new drugs for prevalent and major diseases, gaining recognition from clinical experts and patients [6] - Yiling's products, such as Lianhua Qingwen capsules and Tongxinluo capsules, have been approved for sale in over 50 countries and regions, showcasing the global reach of traditional Chinese medicine [6] Group 4 - As a national key high-tech enterprise, Yiling Pharmaceutical adheres to the principle of "inheritance and innovation for the benefit of humanity," actively engaging in social responsibility initiatives [7] - The company has achieved a water resource reuse rate of 97% through clean production and low-carbon energy practices, contributing to green development [7] - Yiling Pharmaceutical has created over 60 high-standard Chinese medicinal herb bases across more than 20 provinces, providing numerous job opportunities and revitalizing rural industries [7]